drugset / Trial / NCT02892110

Varenicline Treatment for Cannabis Use Disorder

NCT02892110

RandomizedParallel-groupDouble-blindTreatment

Summary

Marijuana is the most commonly used illicit drug. There is high demand for effective interventions for cannabis use disorder, yet few specific treatments for have been developed. This study will evaluate the efficacy of varenicline for reducing marijuana use in people who use marijuana frequently.

Timeline

Start
2017-02-13
Primary completion
2018-11-08
Completion
2018-11-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 2 mg